Literature DB >> 28578017

Functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene increased the risk of prostate cancer in a sample of Iranian population.

Behzad Narouie1, Seyed Amir Mohsen Ziaee1, Abbas Basiri1, Mohammad Hashemi2.   

Abstract

MicroRNAs (miRNAs), a class of non-coding RNAs, bind to the 3' untranslated regions (3'-UTRs) of target mRNAs and regulate gene expression. Genetic variations in miRNA binding domains influence the susceptibility to several diseases such as cancer. Several studies investigated the impact of single-nucleotide polymorphism (SNP) rs16917496 T>C within the 3'-UTR of SETD8 on cancer susceptibility, but the results were controversial. In addition, no study has been conducted to inspect the impact of this SNP in prostate cancer (PCa). Thus, the present study aimed to find out the possible association between rs16917496 polymorphism at the 3'UTR of SETD8 and PCa risk. This case-control study was done on 169 patients with pathologically confirmed PCa and 182 benign prostatic hyperplasia (BPH). Genotyping was done using PCR-RFLP method. The findings revealed that rs16917496 variant significantly increased the risk of PCa in codominant (OR=2.54, 95%CI=1.50-4.30, p<0.001, TC VS TT and OR=3.03, 95%CI=1.63-5.66, p<0.001, CC vs TT), dominant (OR=2.86, 95%CI=1.62-4.43, p<0.001, p<0.001). The C allele significantly increased the risk of PCa (OR=1.72, 95%CI=1.28-2.33, p<0.001) compared to T allele. In conclusion, the findings indicated that rs16917496 polymorphism may be a risk for predisposition to PCa in an Iranian population. Further studies with larger sample sizes and different ethnicities are required to confirm our findings.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Polymorphism; Prostate cancer; SETD8; miRNA-502

Mesh:

Substances:

Year:  2017        PMID: 28578017     DOI: 10.1016/j.gene.2017.05.060

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Downregulation of microRNA-193-3p inhibits the progression of intrahepatic cholangiocarcinoma cells by upregulating TGFBR3.

Authors:  Yu-Long Han; Jia-Jun Yin; Jian-Jun Cong
Journal:  Exp Ther Med       Date:  2018-03-14       Impact factor: 2.447

2.  Telomerase reverse transcriptase activates transcription of miR500A to inhibit Hedgehog signalling and promote cell invasiveness.

Authors:  Manuel Bernabé-García; Elena Martínez-Balsalobre; Diana García-Moreno; Jesús García-Castillo; Beatriz Revilla-Nuin; Elena Blanco-Alcaina; Victoriano Mulero; Francisca Alcaraz-Pérez; María L Cayuela
Journal:  Mol Oncol       Date:  2021-05-02       Impact factor: 6.603

3.  The polymorphisms of miRNA-binding site in MLH3 and ERCC1 were linked to the risk of colorectal cancer in a case-control study.

Authors:  Qianye Zhang; Xiao Zheng; Xiaoxia Li; Deyu Sun; Ping Xue; Guopei Zhang; Mingyang Xiao; Yuan Cai; Cuihong Jin; Jinghua Yang; Shengwen Wu; Xiaobo Lu
Journal:  Cancer Med       Date:  2018-03-08       Impact factor: 4.452

4.  Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population: A case-control study.

Authors:  Minhao Zhang; Yali Wang; Can Wang; Zonghao You; Shuqiu Chen; Qingfang Kong; Bin Xu; Chunhui Liu; Ming Chen
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

5.  The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population.

Authors:  Li Zhang; Xiaoping Li; Jiang Lu; Yi Qian; Tao Qian; Xing Wu; Qinghua Xu
Journal:  Pharmgenomics Pers Med       Date:  2021-04-23

6.  miR‑448 targets Rab2B and is pivotal in the suppression of pancreatic cancer.

Authors:  Jing Jin; Yingsheng Wu; Dongkai Zhou; Qiang Sun; Weilin Wang
Journal:  Oncol Rep       Date:  2018-07-12       Impact factor: 3.906

7.  The association between rs16917496 T/C polymorphism of SET8 gene and cancer risk in Asian populations: a meta-analysis.

Authors:  Hui-Xia Wei; Guo-Xiang Tian; Ju-Kun Song; Lian-Jie Yang; Yu-Pei Wang
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.